Triostat (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Triostat drug offered from Par Pharmaceutical, Inc.. This l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | liothyronine sodium |
| SUBSTANCE NAME: | LIOTHYRONINE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-05-01 |
| END MARKETING DATE: | 0000-00-00 |
Triostat HUMAN PRESCRIPTION DRUG Details:
| Item Description | Triostat from Par Pharmaceutical, Inc. |
| LABELER NAME: | Par Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(ug/mL) |
| START MARKETING DATE: | 2013-05-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42023-120_480ffe8b-5e43-45bc-be8b-bc5731cfbe6d |
| PRODUCT NDC: | 42023-120 |
| APPLICATION NUMBER: | NDA020105 |
Other LIOTHYRONINE SODIUM Pharmaceutical Manufacturers / Labelers:
